Navigation Links
Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance
Date:7/22/2009

6 percent compared with the second quarter of 2008. U.S. sales increased 4 percent to $105.7 million, due to higher net effective selling prices, partially offset by lower demand. Sales outside the U.S. increased 10 percent, to $37.1 million, driven by increased demand and higher prices, partially offset by the unfavorable impact of foreign exchange rates.

Byetta((R))

Lilly reports in collaboration revenue its 50 percent share of Byetta's gross margin in the U.S., and in product sales 100 percent of Byetta sales outside the U.S., and its sales of Byetta pen delivery devices to its partner, Amylin Pharmaceuticals. For the second quarter, Lilly recognized total revenue of $114.6 million for Byetta, an increase of 13 percent, comprised of collaboration revenue of $79.9 million and product sales of $34.7 million.

Worldwide sales of Byetta were $205.7 million in the second quarter of 2009, a 6 percent increase compared with the second quarter of 2008, driven by growth in international markets. U.S. sales of Byetta declined 1 percent to $175.1 million compared with the second quarter of 2008, while sales of Byetta outside the U.S. were $30.6 million.

Erbitux((R))

Lilly reports in collaboration revenue the net royalties received from its Erbitux collaboration partners, and in product sales the revenue from manufactured product sold to these partners. For the second quarter, Lilly recognized total revenue of $99.7 million for Erbitux, comprised of collaboration revenue of $75.8 million and product sales of $23.9 million.

Animal Health

Worldwide sales of animal health products in the second quarter of 2009 were $275.4 million, an increase of 8 percent compared with the second quarter of 2008. U.S. sales grew 32 percent, to $154.2 million, primarily due to the inclusion of sales from the Posilac((R)) acquisition completed in October,
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine news :

1. Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM)
2. Lilly Celebrates Its 35th Year as a Supporter of the Indiana Black Expo
3. Lilly Sets Date and Conference Call for Second-Quarter 2009 Financial Results Announcement
4. Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection)
5. Lilly Declares Third-Quarter Dividend
6. New Therapies, Including Novel Biologic Agents from Elan/Wyeth and Eli Lilly, Will Drive Robust 11 Percent Annual Growth In the Alzheimers Disease Market
7. Eli Lilly and Company Announces New Drug Discovery Initiative
8. NAACP & Nine Class Reps File Motion for Class Certification Against Eli Lilly in Pervasive Discrimination Case
9. ICON Selected to Manage Lilly Clinical Trial Site Set Up and Monitoring in Europe
10. Bart Peterson to Join Lilly Leadership Team
11. Lilly Resubmits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... new marketing techniques, life coaching company puts free i-phone ... worldwide!, http://itunes.apple.com/us/app/attainment-life-management/id345691804?mt=8 . For the Free download. , ... ... 2009 -- Utah based Attainment Life Management & Coaching ... want everything in life simplified into one little hand ...
(Date:12/16/2009)... Texas, Dec. 16 Austin,s Custom Tops ... countertops, co-sponsored, with Ryan Gray and Hill Country Home ... West on Wednesday, December 9th. Fifty people showed up ... their way through platefuls of sliders in support of ... What started as a casual bet over who could ...
(Date:12/16/2009)... -- Every year in the United States, 160,000 cases ... of the disease, making it the second leading cause ... , As researchers and clinicians fervently look for causes ... of studies producing more and more promising results ... genetics at Case Western Reserve University School of Medicine ...
(Date:12/16/2009)... 16 Allscripts (Nasdaq: MDRX ) ... results for the three and six months ended ... on Monday, January 11, 2010. Allscripts management will ... the company,s earnings and other information at 8:30 ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ,, Allscripts fiscal ...
(Date:12/16/2009)... Dec. 16 HealthSciences Institute will ... care professionals, teams and organizations who serve ... chronic diseases in employer, health plan, medical ... collaborative will offer free, noncommercial webinars on ... disease prevention, management and care improvement. Each ...
Breaking Medicine News(10 mins):Health News:Attainment Life Management & Coaching has just Debuted its Free Application for I-Phone and I-Touch Users 2Health News:Austin-Based Business Co-Sponsors Gastric Feat for Charity 2Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 2Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 3Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 2Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 3Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 4Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 2Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 3
... identify and appropriately treat breast cancer in men, according ... M.D. Cancer Center in Houston, TX. , Image ... breast cancer were reviewed during the study. "The findings ... itself as a mass with an irregular shape and ...
... stenosis, according to a large study performed at Leiden ... The study consisted of 1,331 patients who had suspected ... coronary artery segments were analyzed during the study. "We ... artery stenosis in our patients; specificity was 91%," said ...
... Rockville, MD Researchers used a new imaging technique ... stages of ocular inflammation in mice, and the technology ... of the eye that may cause blindness. , The ... Topical Endoscopic Fundal Imaging with Histologic and Cellular Infiltrate ...
... million grant from the Bill & Melinda Gates Foundation ... aimed at improving health outcomes in Uganda and East ... Global Health, and the Makerere University College of Health ... the faculties of medicine, nursing, and public health at ...
... Dec. 1 As President Bush seeks,to push through ... especially,adversely impact healthcare services and workplace safety, the California,Nurses ... web browsers to help "send Bush packing,", http://www.SendBushPacking.com . ... offers an interactive game highlighting some of the "midnight,rules" ...
... Mach One Corporation,(Pink Sheets: MNCN), a biological solutions company ... to the agricultural and consumer,market, announced today that Mr. ... upon the closing of the acquisition of Pacific Rim,Foods ... Mr. Ballantyne is an officer and/or ...
Other Medicine News:Health News:New technique captures high-res images of full retina 2Health News:Johns Hopkins and Makerere University to collaborate on African health education initiative 2Health News:Johns Hopkins and Makerere University to collaborate on African health education initiative 3Health News:Citing 'Midnight Rules' to Erode Health and Safety, Nurses Unveil New Website to Send Bush Packing 2Health News:Mr. Tad Ballantyne to Join Mach One Board of Directors 2
(Date:12/16/2009)... A new application developed ... clinical review of specialty pharmaceuticals has increased health ... reviewed while reducing costs. ,, AIM, a leading ... health plan clients representing over 35 million consumers ... WLP ), adapted the successful clinical ...
(Date:12/16/2009)... 16 AVAX Technologies, Inc. (Pink Sheets: ... it recently closed a bridge loan financing (the ... Warrant Purchase Agreement (the "Agreement") with Firebird Global ... the Company sold a convertible promissory note, due ... of US$1,400,000, and issued a warrant to purchase ...
(Date:12/16/2009)... 16 Boston Scientific Corporation (NYSE: ... Directors has elected Nelda Connors as a Director. ... Electrical and Metal Products division of Tyco International. ... holding several positions in operations and general management. ... number of executive and management capacities with Ford, Chrysler ...
Breaking Medicine Technology:American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4AVAX Technologies, Inc. Closes Bridge Financing 2AVAX Technologies, Inc. Closes Bridge Financing 3AVAX Technologies, Inc. Closes Bridge Financing 4Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 2Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 3Effect of Strict Diabetes Control on Heart Still Unclear 48348 1Effect of Strict Diabetes Control on Heart Still Unclear 48348 2Effect of Strict Diabetes Control on Heart Still Unclear 48348 3PHRs Protect Families From the Harshest Realities of Natural Disasters 48345 1PHRs Protect Families From the Harshest Realities of Natural Disasters 48345 2PHRs Protect Families From the Harshest Realities of Natural Disasters 48345 3Lumbar Spinal Stenosis Surgery at the Olympia Medical Center 48340 1Lumbar Spinal Stenosis Surgery at the Olympia Medical Center 48340 2
... the 31st European Cystic Fibrosis Conference -, ... 12 /PRNewswire/,-- PTC Therapeutics, Inc. (PTC) today announced ... cystic fibrosis (CF). Results from an Israeli Phase ... treatment in adult,patients with nonsense-mutation-mediated CF demonstrated statistically,significant ...
... Data from Positive Phase 2a Trial, WALTHAM, ... ) today announced that based on feedback from ... initiate a Phase 2b clinical,trial of RG2417, an ... later this year. This will be a multi-center, ...
Other Medicine Technology:PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity 2PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity 3PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity 4PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity 5Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 2Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 3Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 4Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 5
... BioTears Oral GelCaps, the patented next-generation ... is designed to systemically address the root ... syndrome. It is suggested in peer-reviewed literature ... of lubricants in other affected parts of ...
... portal to QC information, providing laboratory personnel ... access their quality control data and other ... enables Bio-Rad customers to access on-demand (InstantQC) ... as convenient online data entry and management. ...
... The OmniPod: a small, lightweight self-adhesive insulin ... directly on your body for up to three ... personalized doses of insulin into your body through ... on instructions that you program into its wireless ...
Inquire...
Medicine Products: